IV Therapies in Cancer Care with Paul Anderson, ND
Worth 1.5 IV CEs (of which .25 are pharm)
While not part of all naturopathic oncology practices, IV therapy is a common modality used. This presentation is designed to discuss the evolution of nutrient IV therapy in oncology, past practice, new data, and future directions. Additionally the challenges presented by the current regulatory environment will be discussed.
Learning Objectives
Discuss the origins of IV therapy in naturopathic oncology
Discuss the lessons learned for common IV therapies from recent research
Describe the use of IV therapy in support of quality of life
Discuss the current regulatory limitations for IV therapy
Worth 1.5 IV CEs (of which .25 are pharm)
While not part of all naturopathic oncology practices, IV therapy is a common modality used. This presentation is designed to discuss the evolution of nutrient IV therapy in oncology, past practice, new data, and future directions. Additionally the challenges presented by the current regulatory environment will be discussed.
Learning Objectives
Discuss the origins of IV therapy in naturopathic oncology
Discuss the lessons learned for common IV therapies from recent research
Describe the use of IV therapy in support of quality of life
Discuss the current regulatory limitations for IV therapy
Worth 1.5 IV CEs (of which .25 are pharm)
While not part of all naturopathic oncology practices, IV therapy is a common modality used. This presentation is designed to discuss the evolution of nutrient IV therapy in oncology, past practice, new data, and future directions. Additionally the challenges presented by the current regulatory environment will be discussed.
Learning Objectives
Discuss the origins of IV therapy in naturopathic oncology
Discuss the lessons learned for common IV therapies from recent research
Describe the use of IV therapy in support of quality of life
Discuss the current regulatory limitations for IV therapy